“Comparative Study of Olopatadine Hydrochloride 0.1% and Emedastine difumarate 0.05% Comparing their Clinical Efficacy and Adverse Effects in Allergic Conjunctivitis”, mfm, vol. 26, no. 5, May 2024, Accessed: Jul. 26, 2026. [Online]. Available: http://medicalforummonthly.com/index.php/mfm/article/view/2774